Anthem Biosciences Limited (NSE:ANTHEM)

Anthem Biosciences Revenue

Anthem Biosciences had revenue of 5.94B INR in the quarter ending September 30, 2026, with 8.00% growth. This brings the company's total for the last twelve months to 20.50B, down -1.29% year-over-year. In the fiscal year ending March 31, 2026, Anthem Biosciences had annual revenue of 21.29B with 15.09% growth. That makes Anthem Biosciences the 16,864th largest company in the world by revenue and 913th in India.

• Revenue (ttm): 20.50B
• Revenue Growth: -1.29%
• P/S Ratio: 25.81
• Revenue / Employee: 8.98M
• Employees: 2,282
• Market Cap: 529.12B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Contract Research Development & Manufacturing Services (CRDMO) 17.73B 83.4%
• Speciality Ingredients 3.52B 16.6%

By Geography

Chart

• Europe 11.45B 53.9%
• North America (USA) 5.80B 27.3%
• India 3.16B 14.9%
• Rest of Asia & Others 837.75M 3.9%

Fiscal year ended Mar 31, 2026 See the full Anthem Biosciences breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	21.29B	2.79B	15.09%
Mar 31, 2025	18.50B	4.30B	30.28%
Mar 31, 2024	14.20B	3.62B	34.24%
Mar 31, 2023	10.58B	-1.83B	-14.74%
Mar 31, 2022	12.41B	1.35B	12.24%

Data Source: S&P Global Market Intelligence Last updated: Nov 3, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 9, 2026

Data Sources Report a data error